Date & Time Apr. 20 (Thu.), 11:10-12:10 Venue Halla Hall Moderators Prof. Sung-Bae Kim (ASAN Medical Center, Korea)
|
|
- Harvey Lee
- 5 years ago
- Views:
Transcription
1
2 Plenary Lecture 1: Past and Future Treatment of HER2-Positive Breast Cancer Date & Time Apr. 20 (Thu.), 11:10-12:10 Venue Halla Hall Prof. Sung-Bae Kim (ASAN Medical Center, Korea) Prof. Martine Piccart (Institut Jules Bordet, Belgium) Satellite Symposium 1: The Role of Faslodex in Advanced Breast Cancer Management Pursuing Long Term Treatment Strategy Date & Time Apr. 20 (Thu.), 12:10-13:10 Venue Halla Hall Prof. Dong-young Noh (Seoul National Univ. Hospital, Korea) Prof. Peter Schmid (Barts Cancer Institute, Queen Mary Univ. of London, United Kingdom) Plenary Lecture 2: What is the Current Concept of Molecular Portraits of Human Breast Tumors Date & Time Apr. 20 (Thu.), 13:30-14:30 Venue Halla Hall Prof. Min-Hyuk Lee (Soonchunhyang Univ. Hospital Seoul, Korea) Prof. Charles M. Perou (Univ. of North Carolina at Chapel Hill, U.S.A.) Symposium 1: Breast Cancer Prevention and Screening Date & Time Apr. 20 (Thu.), 14:40-15:50 Venue Halla Hall Prof. Eun Sook Lee (National Cancer Center, Korea) Prof. Steven A Narod (Dalla Lana School of Public Health, Univ. of Toronto, Canada) Breast Cancer Screening: Harm or Good? Prof.Steven A Narod (Dalla Lana School of Public Health, Univ. of Toronto, Canada) Assessment of Breast Cancer Risk with Genetic Polymorphisms Dr. Antonis Antoniou (Univ. of Cambridge, United Kingdom) Germline Testing for Hereditary Cancer with Multigene Panel Prof. Po-Han Lin (National Taiwan Univ. Hospital, Taiwan)
3 Panel Discussion 1: Elderly Breast Cancer Date & Time Apr. 20 (Thu.), 14:40-15:50 Venue Lotus Hall Prof. Janice Tsang (Hong Kong Breast Oncology Group (HKBOG), Hong Kong) Comprehensive Geriatric Assessment for Elderly Patients Prof. Jee Hyun Kim (Seoul National Univ. Bundang Hospital, Korea) Local Therapy Prof. Seho Park (Yonsei Univ. College of Medicine, Korea) Systemic Therapy Prof. Janice Tsang (Hong Kong Breast Oncology Group (HKBOG), Hong Kong) Oral Presentation 1: Date & Time Apr. 20 (Thu.), 14:40-15:50 Venue Weolla Room Prof. Jeong Soo Kim (The Catholic Univ. of Korea, Uijeongbu St. Mary's Hospital, Korea) Prof. Woo-Chan Park (The Catholic Univ. of Korea, Yeouido St. Mary's Hospital, Korea) TBD Education Session 1: New Issues in Cancer Research and Treatment Date & Time Apr. 20 (Thu.), 16:00-17:10 Venue Halla Hall Prof. Woong-Yang Park (Samsung Medical Center, Korea) Prof. Naoto Ueno (The Univ. of Texas, MD Anderson Cancer Center, U.S.A.) Clinical Utility of Liquid Biopsy in Cancer Prof. Byung-Joo Chae (Seoul St.Mary's Hospital, Korea) Targeted Panel Sequencing Prof. Woong-Yang Park (Samsung Medical Center, Korea) New Issues in Identifying Cancer Driver Prof. Tae-Min Kim (College of Medicine, The Catholic Univ. of Korea, Korea)
4 Panel Discussion 2: Special Issues in Stage IV Breast Cancer Date & Time Apr. 20 (Thu.), 16:00-17:10 Venue Lotus Hall Prof. Jin Zhang (Tianjin Medical Univ. Cancer Center, China) Surgery for Stage IV Breast Cancer: No Benefit at All? Prof. Jin Zhang (Tianjin Medical Univ. Cancer Center, China) New Therapeutic Strategy for CNS Metastases in Breast Cancer Prof. Hee Kyung Ahn (Gachon Univ. Gil Medical Center, Korea) How Long Should We Treat Patients with Metastatic Breast Cancer? Is Cure Possible? Prof. Louis Chow (Macau Univ. of Science and Technology, Hong Kong) Satellite Symposium 2: Dose Intensity and the Importance of Febrile Neutropenia Prevention Date & Time Apr. 21 (Fri.), 07:30-08:10 Venue Halla Hall TBD Prof. Yeon Hee Park (Samsung Medical Center, Korea) Plenary Lecture 3: Has Axillary Clearance Become Obsolete? Date & Time Apr. 21 (Fri.), 08:30-09:30 Venue Halla Hall Prof. Soo-Jung Lee (Yeungnam Medical Center, Korea) Prof. Emiel Rutgers (Netherlands Cancer Institute, Netherlands)
5 Symposium 2: Immuno-Oncology - Where We Are? Date & Time Apr. 21 (Fri.), 09:40-10:50 Venue Halla Hall Prof. Kyong Hwa Park (Korea Univ. Anam Hospital, Korea) Prof. Mary L. Disis (Univ. of Washington, U.S.A.) Immune Check-Point Blockade for Breast Cancer Prof. Peter Schmid (Barts Cancer Institute, Queen Mary Univ. of London, United Kingdom) Immune Approaches to the Treatment of Breast Cancer, Around the Corner? Dr. Yasir Nagarwala (Merck & Co., Inc., U.S.A.) Immune Monitoring for Immuno-Oncology Clinical Trials Prof. Mary L. Disis (Univ. of Washington, U.S.A.) Invited Oral Presentation: Date & Time Apr. 21 (Fri.), 09:40-10:50 Venue Lotus Hall Prof. Sang Seol Jung (Bundang CHA Hospital, Korea) Prof. Yoon Sim Yap (National Cancer Centre Singapore, Singapore) Subgroup Analysis of Asian Population Among PALOMA-2 Trials Prof. In Hae Park (National Cancer Center, Korea) Breast MRI Monitoring for Young Breast Cancer Patients after Breast Conservation Therapy: A Multicenter Prospective Study Prof. Woo Kyung Moon (Seoul National Univ. Hospital, Korea) Premenopausal Patient With Hormone Responsive, HER2 Negative, Lymph Node Positive Breast Cancer Prof. Hee-Jeong Kim (Asan Medical Center, Korea) First-Line Ribociclib + Letrozole In Postmenopausal Asian Women With Hormone Receptor-Positive (Hr+), Her2-Negative (Her2-) Advanced Breast Cancer (Abc): A Subgroup Analysis Of Monaleesa-2 Prof. Yoon Sim Yap (National Cancer Centre Singapore, Singapore
6 Symposium 3: Young Age Session Date & Time Apr. 21 (Fri.), 11:00-12:10 Venue Halla Hall Prof. Jung Sil Ro (National Cancer Center, Korea) Prof. Shiji Ohno (Cancer Institute Hospital, Japan) Fertility Preservation Dr. Elizabeth Ginsburg (The Brigham and Women's Hospital, U.S.A.) Chemotherapy- Endocrine Therapy Sequence in Premenopausal Patients Prof. Yeon Hee Park (Samsung Medical Center, Korea) Long-Term Toxicity of Endocrine Therapy Prof. Shinji Ohno (Cancer Institute Hospital, Japan) Education Session 2: Mutational Landscape and Its Implications for Treatment of Breast Cancer Date & Time Apr. 21 (Fri.), 11:00-12:10 Venue Lotus Hall Prof. Kyung Hae Jung (ASAN Medical Center, Korea) Prof. Charles M. Perou (Univ. of North Carolina at Chapel Hill, U.S.A.) Overcoming Heterogeneity: Single Cell Sequencing of Breast Cancer Prof. Wonshik Han (Seoul National Univ. Hospital, Korea) Practical Implications of Next Generation Sequencing in Breast Cancer: Promises and Challenges Prof. Naoto Ueno (The Univ. of Texas, MD Anderson Cancer Center, U.S.A.) Molecular Heterogeneity of Triple-Negative Breast Cancer Prof. Charles M. Perou (Univ. of North Carolina at Chapel Hill, U.S.A.) Satellite Symposium 3: Recent Insight into Clinic for HER2+ mbc Patients Date & Time Apr. 21 (Fri.), 12:10-13:10 Venue Halla Hall Prof. Chanheun Park (Kangbuk Samsung Hospital, Korea) Prof. Tae-Yong Kim (Seoul National Univ. Hospital, Korea)
7 Plenary Lecture 4: The Evolving Role of Immune Regulation in Breast Cancer Date & Time Apr. 21 (Fri.), 13:30-14:30 Venue Halla Hall Prof. Young-Hyuck Im (Samsung Medical Center, Korea) Prof. Mary L. Disis (Univ. of Washington, U.S.A.) Nursing Session: Management of Metastatic, Recurrent and Intractable Breast Cancer Date & Time Apr. 21 (Fri.), 13:30-15:10 Venue Weolla Room Prof. Mi Young Kang (Cheil General Hospital, Korea) Survivorship Issues of the Metastatic, Recurrent and Intractable Breast Cancer Dr. Yaelim Lee (Yeouido St. Mary s Hospital, Korea) Nursing Care in Bone Metastasis Ms. Hyejin Cho (Ewha Womans Univ. Mokdong Hospital, Korea) Nursing Care in Visceral Metastasis Ms. Seung Hee Seon (Korea Univ. Guro Hospital, Korea) Specialist Nursing Roles for the Patient with Metastatic, Recurrent and Intractable Breast Cancer Ms. Su jin Lee (Dankook Univ. Hospital, Korea) Complementary and Alternative Therapies Prof. Eun-Young Jun (DaeJeon Univ., Korea) ABRCA & HBOC: ABRCA & HBOC Session Date & Time Apr. 21 (Fri.), 14:30-15:50 Venue Lotus Hall Prof. Seigo Nakamura (Showa Univ. School of Medicine, Korea) Breast Cancer Genetics- How is it Changing Our Practice Prof. Ava Kwong (The Univ. of Hong Kong, Hong Kong) Panel Testing and SNP Testing (Polygenic Risk Score) in Asian Women Prof. Soo-Hwang Teo (Cancer Research Malaysia, Malaysia) Breast Cancer Genetics and Cancer Policy Prof. Steven A Narod (Dalla Lana School of Public Health, Univ. of Toronto, Canada) Genetic Susceptibility to Breast Cancer: Roles of High- Moderate- and Modest-Penetrance Alleles Prof. David Goldgar (Univ. of Utah School of Medicine, U.S.A.)
8 Symposium 4: Challenges in the Implementation of Biosimilar: New Frontiers in Oncology Date & Time Apr. 21 (Fri.), 14:40-15:50 Venue Halla Hall Prof. Joon Jeong (Gangnam Severance Hospital, Korea) Prof. Xavier Pivot (Univ. Hospital of Besancon, France) Clinical Considerations for the Development of Biosimilars in Oncology Dr. Chul Kim (Samsung Bioepis Co., Ltd., Korea) G-CSF (PEG-GCSF) Biosimilar: Clinical Application and Experience Prof. Fumikata Hara (National Hospital Organization, Japan) Trastuzumab Biosimilar Prof. Xavier Pivot (Univ. Hospital of Besancon, France) Panel Discussion 3: Minimizing Local Therapy Date & Time Apr. 21 (Fri.), 16:00-17:10 Venue Halla Hall Prof. Yong-Sheng Wang (Shandong Cancer Hospital Affiliated to Shandong Univ., China) Do We Need Excision in ccr Patients after Neoadjuvant Chemotherapy Prof. Han-Byoel Lee (Seoul National Univ. Hospital, Korea) Can We Omit Sentinel Lymph Node Biopsy in Some Patients Prof. Jeong Eon Lee (Samsung Medical Center, Korea) Extent and Role of Radiation Therapy in pcr Patients Prof. Yong Bae Kim (Yonsei Cancer Center, Korea) Panel Discussion 4: Role of Imaging in the Era of ALND Omitting of N1 Breast Cancer Date & Time Apr. 21 (Fri.), 16:00-17:10 Venue Lotus Hall Prof. Emiel Rutgers (Netherlands Cancer Institute, Netherlands) USG or FNA for Predicting Node Positive in Breast Cancer Prof. Chiun-Sheng Huang (National Taiwan Univ. Hospital, National Taiwan Univ. College of Medicine, Taiwan) Accuracy of PET for Lymph Node Evaluation Prof. Emiel Rutgers (Netherlands Cancer Institute, Netherlands) Nomogram to Predict 3 or More Lymph Node Metastasis Prof. Wonshik Han (Seoul National Univ. Hospital, Korea)
9 Satellite Symposium 4: Prognostic Diagnosis for HR+/HER2- Early Breast Cancer Patient Based on the Algorithm through the Gene Expression Signature Date & Time Apr. 21 (Fri.), 17:30-18:20 Venue Halla Hall Prof. Byung-Joo Song (The Catholic Univ. of Korea, Seoul St. Mary's Hospital, Korea) Prof. Young Kee Shin (Seoul National Univ., Korea) Satellite Symposium 5: Expanding Horizons-CDK4/6 Inhibitors in HR+ Breast Cancer Date & Time Apr. 22 (Sat.), 07:30-08:10 Venue Halla Hall Prof. Nam-Sun Paik (Ewha Womans Univ. Cancer Center for Women, Korea) Prof. Sung-Bae Kim (ASAN Medical Center, Korea) Plenary Lecture 5: Haute Couture Tailoring of Radiation Therapy in Breast Cancer Date & Time Apr. 22 (Sat.), 08:30-09:30 Venue Halla Hall Prof. Chang-Ok Suh (Yonsei Cancer Center, Yonsei Univ. Health System, Korea) Prof. Philip Poortmans (Institut Curie Paris, Netherlands) Symposium 5: To Treat or Not Date & Time Apr. 22 (Sat.), 09:40-10:50 Venue Halla Hall Prof. Philip Poortmans (Institut Curie Paris, Netherlands) Prof. Doo Ho Choi (Samsung Medical Center, Korea) Post-BCS WBRT: Invasive Carcinoma & DCIS Prof. Su Ssan Kim (Univ. of Ulsan College of Medicine, Asan Medical Center, Korea) PMRT in pn1 Prof. Hae Jin Park (Hanyang Univ. Hospital, Korea) IMN: Balancing Risks and Benefits Prof. Philip Poortmans (Institut Curie Paris, Netherlands)
10 Survivorship Session: Advances in Breast Cancer Survivor's Care Date & Time Apr. 22 (Sat.), 09:40-10:50 Venue Lotus Hall Prof. Jung Han Yoon (Chonnam National Univ. Hwasun Hospital, Korea) Prof. Ava Kwong (The Univ. of Hong Kong, Hong Kong) E-health Innovation in Breast Cancer Prof. Miyako Takahashi (National Cancer Center, Japan) Life after Breast Cancer in Australia Prof. Hyukjai Shin (Myongji Hospital, Medical School of Seonam Univ., Korea) Health Status and Healthcare Utilization of Breast Cancer Survivors Dr. Jihyoun Lee (Soonchunhyang Univ. Hospital, Korea) Oral Presentation 2: Date & Time Apr. 22 (Sat.), 09:40-10:50 Venue Weolla Room Prof. Young Up Cho (Inha Univ. Hospital, Korea) Prof. Ho Yong Park (Kyungpook National Univ. Hospital, Korea) TBD Symposium 6: Personalized Therapy Date & Time Apr. 22 (Sat.), 10:50-12:00 Venue Halla Hall Prof. Joohyuk Sohn (Yonsei Cancer Center, Korea) Prof. Martine Piccart (Institut Jules Bordet, Belgium) How to Interpret the Omics Big Data and Apply to the Clinical Practice Dr. Yu Shyr (Vanderbilt Univ. Medical Center, U.S.A.) Personalized Adjuvant Therapy Based on Clinical Trials in Breast Cancer Prof. Martine Piccart (Institut Jules Bordet, Belgium) Where are We Now, to the Precision Medicine Prof. Masakazu Toi (Kyoto Univ. Hospital, Japan)
11 Education Session 3: Cell Cycle, CDKs and Breast Cancer: A Changing Paradigm Date & Time Apr. 22 (Sat.), 10:50-12:00 Venue Lotus Hall Prof. Seock-Ah Im (Seoul National Univ., Korea) Dr. Melanie Cruz (Philippine Breast Cancer Society, Philippines) Cell Cycle Regulation and Targeting CDK 4/6 for Treatment of Breast Cancer Prof. Seock-Ah Im (Seoul National Univ., Korea) CDK 4/6 Inhibitors for the Treatment of Breast Cancer: A Review of Clinical Data Prof. Jin-Hee Ahn (ASAN Medical Center, Korea) Ongoing Clinical Trials Combining CDK 4/6 Inhibitors and Related Biomarkers Dr. Soohyeon Lee (Pfizer Oncology, Korea) Oral Presentation 3: Date & Time Apr. 22 (Sat.), 10:50-12:00 Venue Weolla Room Prof. Tae Hyun Kim (Inje Univ. Busan Paik Hospital, Korea) Prof. Lee Su Kim (Hallym Univ. Sacred Heart Hospital, Korea) TBD
Global Breast Cancer Conference 2019 (GBCC 2019) with Annual Meeting of Korean Breast Cancer Society (KBCS)
It is our great honor to invite you to the Global Breast Cancer Conference 2019 (GBCC 2019), which will be held at Songdo ConvensiA in Incheon, Korea, from April 25 (Thu) to 27 (Sat), 2019. Hosted by the
More informationQuality of life (QoL) in metastatic breast cancer patients with. maintenance paclitaxel plus gemcitabine (PG) chemotherapy:
Quality of life (QoL) in metastatic breast cancer patients with maintenance paclitaxel plus gemcitabine (PG) chemotherapy: results from phase III, multicenter, randomized trial of maintenance chemotherapy
More informationGBCC2016. April 28 (Thu) - 30 (Sat), 2016 The Shilla Jeju Hotel, Jeju Island, Korea
GBCC2016 Global Breast Cancer Conference 2016 www.gbcc.kr April 28 (Thu) - 30 (Sat), 2016 The Shilla Jeju Hotel, Jeju Island, Korea Better Thinking for Better Life: Exploring Advancing and Transforming
More informationAOSpine Principles Symposium Daegu
KOREA Course program AOSpine Principles Symposium Daegu March 5, 2016 Daegu, South Korea AOSpine the leading global academic community for innovative education and research in spine care, inspiring lifelong
More informationJournal of Breast Cancer
Journal of Breast Cancer ORIGINAL ARTICLE J Breast Cancer 2017 September; 20(3): 264-269 Clinicopathologic Characteristics of Pregnancy-Associated Breast Cancer: Results of Analysis of a Nationwide Breast
More information2017 Obesity Fact Sheet
2017 Fact Sheet Welcome message 2017 Fact Sheet Dear Colleagues, It is my great honor and pleasure to publish the 2017 Fact Sheet of the Korean Society for the Study of (KSSO). The 2017 Fact Sheet is the
More informationResult of screening and surveillance colonoscopy in young Korean adults < 50 years
SEP 25, 2017 Result of screening and surveillance colonoscopy in young Korean adults < 50 years Jae Myung Cha, MD. PhD. Department of Internal Medicine, Kyung Hee University Hospital at Gang Dong, Kyung
More informationTrial of Everolimus-Eluting Stents or Bypass Surgery for Coronary Disease (BEST Trial)
Trial of Everolimus-Eluting Stents or Bypass Surgery for Coronary Disease (BEST Trial) Seung-Jung Park, MD, PhD On behalf of the BEST investigators Professor of Medicine, University of Ulsan College of
More informationOptimal Duration of Clopidogrel Therapy with DES to Reduce Late Coronary Arterial Thrombotic Event. The DES LATE Trial
Optimal Duration of Clopidogrel Therapy with DES to Reduce Late Coronary Arterial Thrombotic Event The DES LATE Trial Cheol Whan Lee, MD, Seung-Jung Park, MD, PhD, On Behalf of the DES LATE Investigators
More informationKim et al. BMC Cancer (2016) 16:319 DOI /s
Kim et al. BMC Cancer (2016) 16:319 DOI 10.1186/s12885-016-2354-6 STUDY PROTOCOL Open Access The role of the addition of ovarian suppression to tamoxifen in young women with hormone-sensitive breast cancer
More informationSERUM CYSTATIN C CONCENTRATION IS A POWERFUL PROGNOSTIC INDICATOR IN PATIENTS WITH CIRRHOTIC ASCITES
SERUM CYSTATIN C CONCENTRATION IS A POWERFUL PROGNOSTIC INDICATOR IN PATIENTS WITH CIRRHOTIC ASCITES YEON SEOK SEO, 1 SOO YOUNG PARK, 2 MOON YOUNG KIM, 3 SANG GYUNE KIM, 4 JUN YONG PARK, 5 HYUNG JOON YIM,
More informationClinical Utility of Actionable Genome Information in Precision Oncology Clinic
Indian Ocean Rim 2017 Laboratory Haematology Congress 2017. 6.18-19, Singapore Clinical Utility of Actionable Genome Information in Precision Oncology Clinic Reimbursement program for NGS panel tests in
More informationSupplementary appendix
Supplementary appendix This appendix formed part of the original submission and has been peer reviewed. We post it as supplied by the authors. Supplement to: Kim BJ, Lee E-J, Kwon SU, et al on behalf of
More informationThe 1 st Congress of Asian Society of Cardiovascular Imaging
The 1 st Congress of Asian Society of Cardiovascular Imaging April 27 (Friday) ~ April 28 (Saturday), 2007 Asan Medical Center, Seoul, Korea Number of Participants : 545 Participants from 26 Countries
More informationAOTrauma Symposium Foot and Ankle
Course program AOTrauma Symposium Foot and Ankle Mar 31-Apr 1, 2017, Gwangju, Korea Home to Trauma & Orthopedics Value statement AOTrauma is committed to improve patient care outcomes through the highest
More informationNam Cheol Park Sae Woong Kim Du Geon Moon Editors. Penile Augmentation
Penile Augmentation Nam Cheol Park Sae Woong Kim Du Geon Moon Editors Penile Augmentation Editors Nam Cheol Park Pusan National University Hospital Busan South Korea Du Geon Moon Korea University Guro
More informationHyun Kee Kim, M.S. Curriculum Vitae
Hyun Kee Kim, M.S. Curriculum Vitae August, 2012 Ⅰ. Personal Information Address - Office. Researcher Molecular Genetic Laboratory, Research Institute of Medical Science, College of Medicine, The Catholic
More informationPROGRAM. Room A (English Session) (Convention 4F) 17 th (Sat) Nov. 08:00-08:25 Registration 08:25-08:30 Opening Remark
Room A (English Session) (Convention 4F) 17 th (Sat) Nov. 08:00-08:25 Registration 08:25-08:30 Opening Remark Postoperative Pain YOUN-WOO LEE (Yonsei Univ., Korea) 08:30-08:55 Epidemiology & Risk Factor
More informationOnly Estrogen receptor positive is not enough to predict the prognosis of breast cancer
Young Investigator Award, Global Breast Cancer Conference 2018 Only Estrogen receptor positive is not enough to predict the prognosis of breast cancer ㅑ Running head: Revisiting estrogen positive tumors
More informationTime / Venue Convention Hall A Convention Hall B. 10:15~10:45 Coffee Break 10:45~11:00 Opening Remarks Plenary Lecture 1 11:00~11:40
September 13-14, 2013 ICLA 2013 IMEABLE September 13 (Fri), 2013 ime / Venue Convention Hall A Convention Hall B 08:15~10:15 Symposium I Basic Research Committee Workshop 10:15~10:45 Coffee Break 10:45~11:00
More informationAOSpine Basic & Advance Course in Spinal Surgery
Program AOSpine Basic & Advance Course in Spinal Surgery Seoul, Korea 13 14, June 2009 CONTENT 3 Welcome to Seoul 4 Course venue & Accommodation 5 Registration form 6 Course information 7 Course Chairperson
More informationAre there the specific prognostic factors for triplenegative subtype of early breast cancers (pt1-2n0m0)?
Are there the specific prognostic factors for triplenegative subtype of early breast cancers (pt1-2n0m0)? Department of General Surgery, Anam Hospital, Korea University, College of Medicine, 126-, Anam-dong
More informationKorean Multicenter Cohort Study of Acute-on- Chronic Liver Failure : Korean Acute-on-Chronic Liver Failure Study (KACLiF)
2015 KASL Single Topic Symposium Korean Multicenter Cohort Study of Acute-on- Chronic Liver Failure : Korean Acute-on-Chronic Liver Failure Study (KACLiF) Do Seon Song Department of Internal Medicine,
More informationKAHBPS-O-PL-01 KAHBPS-O-PL-02
KAHBPS-O-PL-01 Proposal of future remnant liver-indocyanine green clearance rate for risk assessment of major hepatectomy - What is its cutoff? Department of Surgery, Asan Medical Center, University of
More informationIncidence and Predictors of Stent Thrombosis after Percutaneous Coronary Intervention in Acute Myocardial Infarction
Incidence and Predictors of Stent Thrombosis after Percutaneous Coronary Intervention in Acute Myocardial Infarction Sungmin Lim, Yoon Seok Koh, Hee Yeol Kim, Ik Jun Choi, Eun Ho Choo, Jin Jin Kim, Mineok
More information2014 Asian Breast Cancer Conference
2014 Asian Breast Cancer Conference Individual Difference, Ethnic Difference, the Challenges of Breast Cancer Care in Asia 4F VIP Room, TICC, Taipei, Taiwan Ultrasound School 08:20-08:30 Welcome Remarks
More informationInvitation. Dear Colleagues, Joong Saeng Cho, M.D.
Invitation Dear Colleagues, It gives me a great pleasure to invite you on behalf of the organizing committee to the 13th Korea-Japan Joint Meeting of Otorhinolaryngology- Head and Neck Surgery 2010. We
More informationPreceptorship at the Yonsei Cancer Center Gastric Cancer Team. Date : July, 2018 Place: Yonsei Cancer Center, Seoul, Korea
Preceptorship at the Yonsei Cancer Center Gastric Cancer Team Date : July, 2018 Place: Yonsei Cancer Center, Seoul, Korea 1 I. Main Topics: - Gastric cancer II. Delegates: Medical oncologists, radiation
More informationFeasibility of Preoperative Axillary Lymph Node Marking with a Clip in Breast Cancer Patients before Neoadjuvant Chemotherapy: A Preliminary Study
[ABS-0078] GBCC 2018 Feasibility of Preoperative Axillary Lymph Node Marking with a Clip in Breast Cancer Patients before Neoadjuvant Chemotherapy: A Preliminary Study Eun Young Kim 1, Kwan Ho Lee 1, Yong
More informationJournal of Breast Cancer
Journal of Breast Cancer ORIGINAL ARTICLE J Breast Cancer 215 March; 18(1): 8-15 http://dx.doi.org/1.448/jbc.215.18.1.8 Survival Improvement in Korean Breast Cancer Patients Due to Increases in Early-Stage
More informationDECISION-CTO. Optimal Medical Therapy With or Without Stenting For Coronary Chronic Total Occlusion. Seung-Jung Park, MD., PhD.
DECISION-CTO Optimal Medical Therapy With or Without Stenting For Coronary Chronic Total Occlusion Seung-Jung Park, MD., PhD. Heart Institute, University of Ulsan College of Medicine Asan Medical Center,
More informationMONALESSA-7: Phase III placebo-controlled study of ribociclib and tamoxifen/nsai + goserelin
First-line ribociclib or placebo combined with goserelin and tamoxifen or a non-steroidal aromatase inhibitor in premenopausal women with hormone receptor-positive, HER2-negative advanced breast cancer:
More informationCURRICULUM VITAE CHUL LEE, M.D., Ph.D
CURRICULUM VITAE CHUL LEE, M.D., Ph.D. --------------------------------- PRESENT TITLE: President, University of Ulsan (Since 3. 2011) Professor of Psychiatry, University of Ulsan College of Medicine (UUCM),
More informationKHUPO 9 TH ANNUAL INTERNATIONAL PROTEOMICS CONFERENCE
FIRST CIRCULAR, JAN 14 TH 2009 KHUPO 9 TH ANNUAL INTERNATIONAL PROTEOMICS CONFERENCE MAR 25-27 TH, 2009 UNIVERSITY CULTURAL CENTER, SEOUL NATIONAL UNIVERSITY, SEOUL, KOREA THEME: PROTEOMICS: FROM DISCOVERY
More informationCURRICULUM VITAE PERSONAL INFORMATION EDUCATION AND TRAINING. Degree Field of Study Institution Years
CURRICULUM VITAE PERSONAL INFORMATION Name: Jung Sun Lee Business Address: University of Ulsan College of Medicine Asan Medical Center 388-1 Pungnap-dong, Songpa-gu Seoul, Republic of Korea Zip code: 138-736
More informationEstablishment of Korean prostate cancer database by the Korean Urological Oncology Society
Original Article - Urological Oncology Investig Clin Urol 217;58:434-439. https://doi.org/1.4111/icu.217.58.6.434 pissn 2466-493 eissn 2466-54X Establishment of Korean prostate cancer database by the Korean
More informationAssociation-heterogeneity mapping identifies an Asian-specific association of the GTF2I locus with rheumatoid arthritis
Supplementary Material Association-heterogeneity mapping identifies an Asian-specific association of the GTF2I locus with rheumatoid arthritis Kwangwoo Kim 1,, So-Young Bang 1,, Katsunori Ikari 2,3, Dae
More informationTargeting CDK 4/6. Jee Hyun Kim, M.D., Ph.D. Seoul National University College of Medicine
2016.04.30 GBCC Education Symposium Targeting CDK 4/6 Jee Hyun Kim, M.D., Ph.D. Seoul National University College of Medicine Contents Cyclins -CDKs in cell cycle control CDK 4/6 in breast cancer Preclinical
More informationDisease-Specific Mortality of Differentiated Thyroid Cancer Patients in Korea: A Multicenter Cohort Study
Original Article Endocrinol Metab 2017;32:434-441 https://doi.org/10.3803/enm.2017.32.4.434 pissn 2093-596X eissn 2093-5978 Disease-Specific Mortality of Differentiated Thyroid Cancer Patients in Korea:
More informationNEOADJUVANT THERAPY FOR BREAST CANCER: LOCAL EXPERT OPINION AND RECENT EVIDENCE
NEOADJUVANT THERAPY FOR BREAST CANCER: LOCAL EXPERT OPINION AND RECENT EVIDENCE Dr. Joanne Chiu Medical Oncology Queen Mary Hospital The University of Hong Kong HONG KONG SURVEY FOR NEOADJUVANT THERAPY
More informationPreoperative risk assessment for lymph node metastasis in endometrial cancer (PALME study) : results of a Korean Gynecologic Oncology Group study
Preoperative risk assessment for lymph node metastasis in endometrial cancer (PALME study) : results of a Korean Gynecologic Oncology Group study Sokbom Kang, 1 Joo-Hyun Nam, 2 Duk-Soo Bae, 3 Jae-Weon
More informationAuthor's response to reviews
Author's response to reviews Title: Prognostic impact of clinicopathologic parameters in stage II/III breast cancer treated with neoadjuvant docetaxel and doxorubicin chemotherapy: paradoxical features
More informationRecent Update in Surgery for the Management of Breast Cancer
Recent Update in Surgery for the Management of Breast Cancer Wonshik Han, MD, PhD Professor, Department of Surgery, Seoul National University College of Medicine Chief of Breast Care Center, Seoul National
More informationThyroid Fine-Needle Aspiration Cytology Practice in Korea
Journal of Pathology and Translational Medicine 2017; 51: 521-527 REVIEW Thyroid Fine-Needle Aspiration Cytology Practice in Korea Yoon Jin Cha Ju Yeon Pyo SoonWon Hong Jae Yeon Seok 1 Kyung-Ju Kim 2 Jee-Young
More informationSeung-Woon Rha, MD, PhD FACC, FAHA, FESC, FSCAI, FAPSIC. Cardiovascular Center, Korea University Guro Hospital, Seoul, Korea.
Controversies in Acute Myocardial Infarction - Is Early Statin Therapy is Beneficial in all Patients?- : Insights from Korea Acute Myocardial Infarction Registry (KAMIR) Seung-Woon Rha, MD, PhD FACC, FAHA,
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Park S-J, Ahn J-M, Kim Y-H, et al. Trial of everolimus-eluting
More informationEGIS BILIARY STENT. 1. Features & Benefits 2. Ordering information 3. References
EGIS BILIARY STENT 1. Features & Benefits 2. Ordering information 3. References 1. Features & Benefits (1) Features Superior flexibility & conformability 4 Types Single bare, Single cover, Double bare,
More informationChanges in the seroprevalence of IgG anti-hepatitis A virus between 2001 and 2013: experience at a single center in Korea
pissn 2287-2728 eissn 2287-285X Original Article Clinical and Molecular Hepatology 214;2:162-167 Changes in the seroprevalence of IgG anti-hepatitis A virus between 21 and 213: experience at a single center
More informationAOPA-KPBA-KPSC 2018 Free Paper Sessions
AOPA-KPBA-KPSC 2018 Title Country Presenting Author Affiliation PL-01 10:50-11:04 AOPA-020 Incidence and Mortality of Second Primary Pancreatic Cancer among Survivors of Digestive System Cancers: a National-wide
More informationDate of Preparation: December 8, 2017 A. GENERAL INFORMATION. 1. Name: Eun Sook KO Citizenship: Republic of Korea
Date of Preparation: December 8, 2017 A. GENERAL INFORMATION 1. Name: Eun Sook KO 2. Email: mathilda0330@gmail.com 3. Citizenship: Republic of Korea B. EDUCATIONAL & TRAINING BACKGROUND Degree Institution
More informationAddictive Benefit of Transarterial Chemoembolization and Sorafenib in Treating Advanced Stage Hepatocelluar Carcinoma: Propensity Analysis
Addictive Benefit of Transarterial Chemoembolization and Sorafenib in Treating Advanced Stage Hepatocelluar Carcinoma: Propensity Analysis Gwang Hyeon Choi, Ju Hyun Shim*, Min-Joo Kim, Min-Hee Ryu, Baek-Yeol
More informationChanges of gastrointestinal condition after H. pylori eradication therapy
Program: Symposium Opening Remarks Symposium 1 S-1-1 S-1-2 Saturday, June 30th, 2018 14:30~14:35 Room 2(2F Niho A) President of the 24th Annual Meeting of JSHR: Kazunari Murakami ( Professor of Faculty
More informationRole of Genetic Counseling Nurse in Breast Cancer. Sung-Won Kim, MD, PhD, FACS CEO & President Daerim St. Mary s Hospital
Role of Genetic Counseling Nurse in Breast Cancer Sung-Won Kim, MD, PhD, FACS CEO & President Daerim St. Mary s Hospital What is hereditary breast cancer? Hereditary (5-10%): Mutated phenotype of a specific
More informationNEW SUBTRACTION ALGORITHMS FOR EVALUATION OF BREAST LESIONS ON DYNAMIC CONTRAST ENHANCED MR MAMMOGRAPHY
A-056 NEW SUBTRACTION ALGORITHMS FOR EVALUATION OF BREAST LESIONS ON DYNAMIC CONTRAST ENHANCED MR MAMMOGRAPHY So Hee Cho, M.D., Byung Gil Choi, M.D., Hak Hee Kim, M.D., Euy Neyng Kim, M.D., Bum-soo Kim,
More informationApplication of big data for population-based studies for liver diseases
The Korean Liver Cancer Ass. 2017 Application of big data for population-based studies for liver diseases Moran Ki, MD., PhD Graduate School of Cancer Science and Policy, National Cancer Center Contents
More information2 nd INTERNATIONAL SEVERANCE ROBOTIC SURGERY SYMPOSIUM
2 nd INTERNATIONAL SEVERANCE ROBOTIC SURGERY SYMPOSIUM in Head and Neck Cancer and 2012-10-06 (Sat.) SYMPOSIUM 09:00-09:10 Congratulatory Remarks Won Sang Lee, M.D. / Chairman Dept. of Otorhinolaryngology,
More informationORIGINAL ARTICLE Pediatrics INTRODUCTION
ORIGINAL ARTICLE Pediatrics http://dx.doi.org/10.3346/jkms.16.31.7.1082 J Korean Med Sci 16; 31: 1082-1088 Early Changes in the Serotype Distribution of Invasive Pneumococcal Isolates from Children after
More informationASCO 2018 Breast Cancer updates. June 29 th 2018 Einav Gal-Yam Sheba MC
ASCO 2018 Breast Cancer updates June 29 th 2018 Einav Gal-Yam Sheba MC Early BC Adjuvant Chemotherapy benefit in HR-pos Nneg BC TAILORX Slide 1 Presented By Joseph Sparano at 2018 ASCO Annual Meeting TAILORx
More informationCurriculum Vitae (Last updated: ) Jin-Gu Lee, PhD
Curriculum Vitae (Last updated: 2016-06-22) Jin-Gu Lee, PhD Laboratory of Molecular Biology NIDDK, National Institutes of Health Building 5, Rm 433 5 Memorial Drive Bethesda, MD 20892 EDUCATION 2004. 3.
More informationCurriculum Vitae. Dissertation Title M.S. Thesis: Regulation of Notch1 signaling by Runx2 during osteoblast differentiation.
Curriculum Vitae Name: Eun-Jung Ann Education Mar.2009 : Ph.D. in Graduate School of Biological Sciences and Technology, Chonnam National University Mar.2007 Feb. 2009: M.S. in Graduate School of Biological
More information: Ajou University College of Medicine, Suwon, Korea; Ajou University College of Medicine, Graduate
CURRICULUM VITAE NAME Hyun Woo Lee, M.D. EDUCATION 1991.3.-2001.2 : Ajou University College of Medicine, Suwon, Korea; Doctor of Medicine 2004.3-2006.2 Ajou University College of Medicine, Graduate School,
More informationIndex. Note: Page numbers of article titles are in boldface type.
Note: Page numbers of article titles are in boldface type. A Adjuvant therapy, for early-stage triple-negative breast cancer, 740 742 in older early-stage breast cancer patients, 790 795 anti-her2-directed
More informationNew Drug Development for Hepatic Insulin Resistance
New Drug Development for Hepatic Insulin Resistance Innovative Drug Research Center for Metabolic and Inflammatory Disease College of Pharmacy Sang Geon Kim AMPK as an energy sensor, (A novel drug target
More informationSi Hyun Bae, 1,2,3 Do Seon Song, 1,2,3 Myeong Jun Song, 1,4 Woo Jin Chung, 1,5
Comparison of efficacy between hepatic arterial infusion chemotherapy and sorafenib in advanced hepatocellular carcinoma with portal vein tumor thrombosis 1,2,3 Si Hyun Bae, 1,2,3 Do Seon Song, 1,2,3 Myeong
More informationPMRT for N1 breast cancer :CONS. Won Park, M.D., Ph.D Department of Radiation Oncology Samsung Medical Center
PMRT for N1 breast cancer :CONS Won Park, M.D., Ph.D Department of Radiation Oncology Samsung Medical Center DBCG 82 b & c Overgaard et al Radiot Oncol 2007 1152 pln(+), 8 or more nodes removed Systemic
More informationNationwide Cancer Incidence in Korea,
Cancer Res Treat. 2009;41(3):122-131 DOI 10.4143/crt.2009.41.3.122 Special Article Nationwide Cancer Incidence in Korea, 2003 2005 Young-Joo Won, Ph.D. 1 Joohon Sung, M.D. 1,2 Kyu-Won Jung, M.S. 1 Hyun-Joo
More informationWhen is Chemotherapy indicated in Advanced Luminal Breast Cancer?
When is Chemotherapy indicated in Advanced Luminal Breast Cancer? Soo-Chin Lee Head & Senior Consultant Department of Haematology-Oncology Clinical Care National University Cancer Institute, Singapore
More informationSeung Hyeok Han, MD, PhD Department of Internal Medicine Yonsei University College of Medicine
Seung Hyeok Han, MD, PhD Department of Internal Medicine Yonsei University College of Medicine The Scope of Optimal BP BP Reduction CV outcomes & mortality CKD progression - Albuminuria - egfr decline
More informationRecent Trend in the Incidence of Premalignant and Malignant Skin Lesions in Korea between 1991 and 2006
J Korean Med Sci 2010; 25: 924-9 ISSN 1011-8934 DOI: 10.3346/jkms.2010.25.6.924 Recent Trend in the Incidence of Premalignant and Malignant Skin Lesions in Korea between 1991 and 2006 We evaluated the
More informationSurfactant Therapy for Neonatal Respiratory Distress Syndrome: A Review of Korean Experiences over 17 Years
J Korean Med Sci 29; 24: 111-8 ISSN 111-8934 DOI: 1.3346/jkms.29.24.6.111 Copyright The Korean Academy of Medical Sciences Surfactant Therapy for Neonatal Respiratory Distress Syndrome: A Review of Korean
More informationClinical activity of fulvestrant in metastatic breast cancer previously treated with endocrine therapy and/or chemotherapy
ORIGINAL ARTICLE 2018 Mar 16. [Epub ahead of print] Clinical activity of fulvestrant in metastatic breast cancer previously treated with endocrine therapy and/or chemotherapy Mi Hwa Heo, Hee Kyung Kim,
More informationPresented on Friday April 5, 2018 (Invited Oral Presentation)
RIBOCICLIB PLUS GOSERELIN AND TAMOXIFEN OR A NON-STEROIDAL AROMATASE INHIBITOR FOR PREMENOPAUSAL WOMEN WITH HR+, HER2 ADVANCED BREAST CANCER IN THE RANDOMIZED PHASE III MONALEESA-7 TRIAL Seock-Ah Im, 1
More informationRisk-reducing Surgery in BRCA mutation carriers
Risk-reducing Surgery in BRCA mutation carriers Daerim St. Mary s Hospital Department of Surgery, Breast Care Center Hereditary Breast Ovarian Cancer Clinic Sung-Won Kim, MD, PhD, FACS Overview of HBOC
More informationAn integrative approach to cancer precision medicine
2017 Korean Society of Gynecologic Oncology Symposium An integrative approach to cancer precision medicine Sung-Yup Cho, M.D., Ph.D. Ewha Institute of Convergence Medicine EWHA WOMANS UNIVERSITY MEDICAL
More informationChange in Cancer Pain Management in Korea Between 2001 and 2006: Results of Two Nationwide Surveys
Vol. 41 No. 1 January 2011 Journal of Pain and Symptom Management 93 Original Article Change in Cancer Pain Management in Korea Between 2001 and 2006: Results of Two Nationwide Surveys Sook Hee Hong, MD,
More informationInes Buccimazza 16 TH UP CONTROVERSIES AND PROBLEMS IN SURGERY SYMPOSIUM
BILATERAL MASTECTOMY IS NOT ROUTINELY JUSTIFIED IN PATIENTS WITH BILATERAL AXILLARY LYMPHADENOPATHY AND ONLY ONE DETECTABLE PRIMARY BREAST CANCER LESION SURGERY SYMPOSIUM Ines Buccimazza Breast Unit Department
More informationESMO SUMMIT MIDDLE EAST 2018
ESMO SUMMIT MIDDLE EAST 2018 Breast Clinical Cases Presentation Hampig Raphael Kourie, MD, MSc, MBioethics Faculty of Medicine, Saint Joseph University of Beirut, Lebanon 6-7 April 2018, Dubai, UAE CONFLICT
More informationDieta Brandsma, Department of Neuro-oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands
What is hot in breast cancer brain metastases? Dieta Brandsma, Department of Neuro-oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands 8th Annual Brain Metastases Research and Emerging Therapy
More informationDIAMOND Study Investigators
Seung-Ho Hur, Wooyeong Jang, Jang-Whan Bae, Dong-Ju Choi, Young-Keun Ahn, Jong-Sun Park, Rak-Kyeong Choi, Dong-Hoon Choi, Joon-Hong Kim, Kyoo-Rok Han, Hun-Sik Park, So-Yeon Choi, Jung-Han Yoon, Hyeon-Cheol
More informationConservative Surgery and Radiation Stage I and II Breast Cancer
Conservative Surgery and Radiation Stage I and II Breast Cancer Variant 1: Premenopausal 41-year-old woman, 1.1-cm GII IDC, upper outer quadrant (UOQ), ER/PR ( ), HER2 ( ), primary excised with lumpectomy,
More informationPerformance of Screening Mammography: A Report of the Alliance for Breast Cancer Screening in Korea
Original Article Breast Imaging http://dx.doi.org/10.3348/kjr.2016.17.4.489 pissn 1229-6929 eissn 2005-8330 Korean J Radiol 2016;17(4):489-496 Performance of Screening Mammography: A Report of the Alliance
More information42nd Korean Society of Ultrasound in Medicine 2011 May 20(Fri) - 21(Sat), 2011 Hall E, Coex, Seoul, Korea
www.ultrasound.or.kr 42nd Korean Society of Ultrasound in Medicine 2011 May 20(Fri) - 21(Sat), 2011 Hall E, Coex, Seoul, Korea Contents 1 Welcome Message 2 Organizing Committee 3 Program at a Glance 4
More informationCURRICULUM VITAE , St.Mary s Hospital, The Catholic University of Korea, Seoul, Korea National Boards of Medical Doctor #28022
CURRICULUM VITAE I. PERSONAL DATA A. Name: Soo-Heon Park, M.D. B. Birth Date: January 21, 1960 C. Birthplace: Weon Ju, Kwang Won Do, Korea D. Citizenship: Korea II. EDUCATION A. Medical Degree: 1978-1984,
More informationClinicopathological Factors Affecting Distant Metastasis Following Loco-Regional Recurrence of breast cancer. Cheol Min Kang 2018/04/05
Abstract No.: ABS-0075 Clinicopathological Factors Affecting Distant Metastasis Following Loco-Regional Recurrence of breast cancer 2018/04/05 Cheol Min Kang Department of surgery, University of Ulsan
More informationWorld Congress of Ultrasonic Piezoelectric Bone Surgery 2013
Information of WCUPS 2013 OVERVIEW Title Subject Interdisciplinary Approach and future Trends in Implant Dentistry Dates 4. 20(Sat) ~ 21 (Sun), 2013 Venue Hotel Hyundai, Gyeongju, Korea Hosted by WAUPS,
More informationDelay of Treatment Initiation Does Not Adversely Affect Survival Outcome in Breast Cancer
pissn 1598-2998, eissn 25-9256 Cancer Res Treat. 216;48(3):962-969 Original Article http://dx.doi.org/1.4143/crt.215.173 Open Access Delay of Treatment Initiation Does Not Adversely Affect Survival Outcome
More informationKorea s Contribution to Radiological Research Included in Science Citation Index Expanded,
Original Article http://dx.doi.org/10.3348/kjr.2012.13.5.523 pissn 1229-6929 eissn 2005-8330 Korean J Radiol 2012;13(5):523-529 Korea s Contribution to Radiological Research Included in Science Citation
More informationSupplementary Appendix
Supplementary Appendix Increased Risk of Atrial Fibrillation and Thromboembolism in Patients with Severe Psoriasis: a Nationwide Population-based Study Tae-Min Rhee, MD 1, Ji Hyun Lee, MD 2, Eue-Keun Choi,
More informationVolume 2. Lecture Notes in Electrical Engineering 215. Kim Chung Eds. IT Convergence and Security IT Convergence and Security 2012.
Lecture Notes in Electrical Engineering 215 Kuinam J. Kim Kyung-Yong Chung Editors IT Convergence and Security 2012 Volume 2 The proceedings approaches the subject matter with problems in technical convergence
More informationpissn , eissn Open Access Original Article
pissn 1598-2998, eissn 25-9256 Original Article https://doi.org/1143/crt.215.473 Open Access Concurrent Chemoradiotherapy with Temozolomide Followed by Adjuvant Temozolomide for Newly Diagnosed Glioblastoma
More informationUpdate on New Perspectives in Endocrine-Sensitive Breast Cancer. James R. Waisman, MD
Update on New Perspectives in Endocrine-Sensitive Breast Cancer James R. Waisman, MD Nothing to disclose DISCLOSURE TAILORx Oncotype Recurrence Score TAILORx Study Design Sparano, J Clin Oncol 2008;26:721-728
More informationAcute kidney injury and outcomes in acute decompensated heart failure in Korea
Acute kidney injury and outcomes in acute decompensated heart failure in Korea Mi-Seung Shin 1, Seong Woo Han 2, Dong-Ju Choi 3, Eun Seok Jeon 4, Jae-Joong Kim 5, Myeong-Chan Cho 6, Shung Chull Chae 7,
More informationOvercome Asthma! Asthma in the elderly
2016 APAAACI Overcome Asthma! Asthma in the elderly Sang-Heon Cho, MD, PhD Department of Internal Medicine Seoul National University College of Medicine Seoul, Korea Elderly asthma : still we do not know
More informationLOTUS (NCT ) randomized phase II trial
Overall survival update of the double-blind placebocontrolled randomized phase 2 LOTUS trial of firstline ipatasertib + paclitaxel for locally advanced/metastatic triple-negative breast cancer Rebecca
More informationProceedings The 68 th Annual Fall Meeting of The Korean Society of Pathologists. 일시 : 2016 년 10 월 19 일 ( 수 ) 21 일 ( 금 ) 장소 : The-K 서울호텔컨벤션센터
대한병리학회제 68 차가을학술대회 초록집 Proceedings The 68 th Annual Fall Meeting of The Korean Society of Pathologists 일시 : 206 년 0 월 9 일 ( 수 ) 2 일 ( 금 ) 장소 : The-K 서울호텔컨벤션센터 대한병리학회 The Korean Society of Pathologists
More informationJournal of Breast Cancer
SPECIAL ARTICLE Journal of Breast Cancer J Breast Cancer 217 March; 2(1): 1-11 Basic Facts of Breast Cancer in Korea in 214: The 1- Overall Survival Progress Eun Hwa Park, Sun Young Min 1, Zisun Kim 2,
More informationEARLY BREAST CANCER, HER2-POSITIVE
EARLY BREAST CANCER, HER2-POSITIVE CLINICAL CASE DISCUSSION Elżbieta Senkus Medical University of Gdańsk Gdańsk, Poland esmo.org DISCLOSURES Honoraria: Amgen, Astellas, AstraZeneca, Bayer, BMS, Celgene,
More informationLow and Lower Fertility
Low and Lower Fertility Ronald R. Rindfuss Minja Kim Choe Editors Low and Lower Fertility Variations across Developed Countries Editors Ronald R. Rindfuss Department of Sociology and Carolina Population
More informationPregnancy outcomes in Korean women with diabetes
Pregnancy outcomes in Korean women with diabetes Sung-Hoon Kim Department of Medicine, Cheil General Hospital & Women s Healthcare Center, Dankook University College of Medicine, Seoul, Korea Conflict
More information